A study to assess the effectiveness of patient information booklet in preventing Hand foot syndrome in cancer patients recieving fluorouracil and capecitabine
Not Applicable
Completed
- Conditions
- Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissueHealth Condition 2: null- Prevention of Hand foot syndrome
- Registration Number
- CTRI/2019/06/019519
- Lead Sponsor
- o sponser
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 81
Inclusion Criteria
Adult male or female diagnosed with cancer and were recieving 5FU or capecitabine
Who could read Hindi or english.
Exclusion Criteria
Who were not willing to participate in the study.
Who cannot read Hindi or English.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevention of Hand foot syndrome <br/ ><br>Increase in knowledgeTimepoint: 3 weeks after intervention
- Secondary Outcome Measures
Name Time Method Association of knowledge with hand foot syndromeTimepoint: at baseline and 21 days after intervention